Literature DB >> 15591520

Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis.

L Xu1, A Y Hui, E Albanis, M J Arthur, S M O'Byrne, W S Blaner, P Mukherjee, S L Friedman, F J Eng.   

Abstract

BACKGROUND: Hepatic stellate cells (HSCs) are a major fibrogenic cell type that contributes to collagen accumulation during chronic liver disease. With increasing interest in developing antifibrotic therapies, there is a need for cell lines that preserve the in vivo phenotype of human HSCs to elucidate pathways of human hepatic fibrosis. We established and characterised two human HSC cell lines termed LX-1 and LX-2, and compared their features with those of primary human stellate cells. METHODS AND
RESULTS: LX-1 and LX-2 were generated by either SV40 T antigen immortalisation (LX-1) or spontaneous immortalisation in low serum conditions (LX-2). Both lines express alpha smooth muscle actin, vimentin, and glial fibrillary acid protein, as visualised by immunocytochemistry. Similar to primary HSCs, both lines express key receptors regulating hepatic fibrosis, including platelet derived growth factor receptor beta (betaPDGF-R), obese receptor long form (Ob-RL), and discoidin domain receptor 2 (DDR2), and also proteins involved in matrix remodelling; matrix metalloproteinase (MMP)-2, tissue inhibitor of matrix metalloproteinase (TIMP)-2, and MT1-MMP, as determined by western analyses. LX-2 have reduced expression of TIMP-1. LX-2, but not LX-1, proliferate in response to PDGF. Both lines express mRNAs for alpha1(I) procollagen and HSP47. Transforming growth factor beta1 stimulation increased their alpha1(I) procollagen mRNA expression, as determined by quantitative reverse transcription-polymerase chain reaction. LX-2, but not LX-1, cells are highly transfectable. Both lines had a retinoid phenotype typical of stellate cells. Microarray analyses showed strong similarity in gene expression between primary HSCs and either LX-1 (98.4%) or LX-2 (98.7%), with expression of multiple neuronal genes.
CONCLUSIONS: LX-1 and LX-2 human HSC lines provide valuable new tools in the study of liver disease. Both lines retain key features of HSCs. Two unique advantages of LX-2 are their viability in serum free media and high transfectability.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15591520      PMCID: PMC1774377          DOI: 10.1136/gut.2004.042127

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  45 in total

Review 1.  Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury.

Authors:  S L Friedman
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

Review 2.  Matrix as a modulator of hepatic fibrogenesis.

Authors:  D Schuppan; M Ruehl; R Somasundaram; E G Hahn
Journal:  Semin Liver Dis       Date:  2001-08       Impact factor: 6.115

Review 3.  Hepatic blood flow regulation by stellate cells in normal and injured liver.

Authors:  D C Rockey
Journal:  Semin Liver Dis       Date:  2001-08       Impact factor: 6.115

Review 4.  Cellular transformation by SV40 large T antigen: interaction with host proteins.

Authors:  S H Ali; J A DeCaprio
Journal:  Semin Cancer Biol       Date:  2001-02       Impact factor: 15.707

5.  Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix.

Authors:  S L Friedman; F J Roll; J Boyles; D M Arenson; D M Bissell
Journal:  J Biol Chem       Date:  1989-06-25       Impact factor: 5.157

6.  DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells.

Authors:  E Olaso; K Ikeda; F J Eng; L Xu; L H Wang; H C Lin; S L Friedman
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 7.  Protein-specific chaperones: the role of hsp47 begins to gel.

Authors:  L M Hendershot; N J Bulleid
Journal:  Curr Biol       Date:  2000 Dec 14-28       Impact factor: 10.834

8.  Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors.

Authors:  D Cassiman; C Denef; V J Desmet; T Roskams
Journal:  Hepatology       Date:  2001-01       Impact factor: 17.425

Review 9.  Hepatic stellate cell behavior during resolution of liver injury.

Authors:  J P Iredale
Journal:  Semin Liver Dis       Date:  2001-08       Impact factor: 6.115

10.  Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers.

Authors:  David Cassiman; Louis Libbrecht; Valeer Desmet; Carl Denef; Tania Roskams
Journal:  J Hepatol       Date:  2002-02       Impact factor: 25.083

View more
  393 in total

1.  Osteopontin contributes to TGF-β1 mediated hepatic stellate cell activation.

Authors:  Xiao Xiao; Yi Gang; Yong Gu; Lina Zhao; Jindong Chu; Jinfeng Zhou; Xiqiang Cai; Hui Zhang; Li Xu; Yongzhan Nie; Kaichun Wu; Zhiguo Liu; Daiming Fan
Journal:  Dig Dis Sci       Date:  2012-06-04       Impact factor: 3.199

2.  Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells.

Authors:  Jiang Li; Yifei Zhang; Ramalinga Kuruba; Xiang Gao; Chandrashekhar R Gandhi; Wen Xie; Song Li
Journal:  Mol Pharmacol       Date:  2011-04-21       Impact factor: 4.436

3.  Natural taurine promotes apoptosis of human hepatic stellate cells in proteomics analysis.

Authors:  Xin Deng; Jian Liang; Zhi-Xiu Lin; Fa-Sheng Wu; Ya-Ping Zhang; Zhi-Wei Zhang
Journal:  World J Gastroenterol       Date:  2010-04-21       Impact factor: 5.742

4.  miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma.

Authors:  Nataliya Razumilava; Steve F Bronk; Rory L Smoot; Christian D Fingas; Nathan W Werneburg; Lewis R Roberts; Justin L Mott
Journal:  Hepatology       Date:  2011-12-19       Impact factor: 17.425

5.  Hepatocyte apoptotic bodies encasing nonstructural HCV proteins amplify hepatic stellate cell activation: implications for chronic hepatitis C.

Authors:  R K Gieseler; G Marquitan; M Schlattjan; J-P Sowa; L P Bechmann; J Timm; M Roggendorf; G Gerken; S L Friedman; A Canbay
Journal:  J Viral Hepat       Date:  2010-08-15       Impact factor: 3.728

6.  Immortalized liver endothelial cells: a cell culture model for studies of motility and angiogenesis.

Authors:  Robert C Huebert; Kumaravelu Jagavelu; Ann F Liebl; Bing Q Huang; Patrick L Splinter; Nicholas F LaRusso; Raul A Urrutia; Vijay H Shah
Journal:  Lab Invest       Date:  2010-07-19       Impact factor: 5.662

7.  Exposure to ambient particulate matter induces a NASH-like phenotype and impairs hepatic glucose metabolism in an animal model.

Authors:  Ze Zheng; Xiaohua Xu; Xuebao Zhang; Aixia Wang; Chunbin Zhang; Maik Hüttemann; Lawrence I Grossman; Lung Chi Chen; Sanjay Rajagopalan; Qinghua Sun; Kezhong Zhang
Journal:  J Hepatol       Date:  2012-08-15       Impact factor: 25.083

8.  Optimization of collagen type I-hyaluronan hybrid bioink for 3D bioprinted liver microenvironments.

Authors:  Andrea Mazzocchi; Mahesh Devarasetty; Richard Huntwork; Shay Soker; Aleksander Skardal
Journal:  Biofabrication       Date:  2018-10-30       Impact factor: 9.954

9.  2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) increases necroinflammation and hepatic stellate cell activation but does not exacerbate experimental liver fibrosis in mice.

Authors:  Cheri L Lamb; Giovan N Cholico; Xinzhu Pu; Gerald D Hagler; Kenneth A Cornell; Kristen A Mitchell
Journal:  Toxicol Appl Pharmacol       Date:  2016-09-28       Impact factor: 4.219

10.  Boyden chamber-based method for characterizing the distribution of adhesions and cytoskeletal structure in HT1080 fibrosarcoma cells.

Authors:  József Tóvári; Krisztina Futosi; Alexandra Bartal; Enikő Tátrai; Alexandra Gacs; István Kenessey; Sándor Paku
Journal:  Cell Adh Migr       Date:  2014-10-31       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.